Primary Intraocular Lymphoma in a Patient with Bilateral Epstein-Barr Virus Panuveitis

Figure 4

One month after starting the antiviral therapy, SD-OCT of the right eye (a) and the left eye (b) shows the exacerbation of the subretinal infiltration during the one-week follow-up period (the top and the middle rows). Two weeks after intravitreal injection of methotrexate and rituximab, significant improvement was observed in macular OCT (bottom row).